Provided by Tiger Trade Technology Pte. Ltd.

Vornado

34.20
-0.2600-0.75%
Volume:1.46M
Turnover:50.08M
Market Cap:6.57B
PE:8.14
High:34.87
Open:34.52
Low:33.79
Close:34.46
52wk High:45.37
52wk Low:29.68
Shares:192.05M
Float Shares:160.15M
Volume Ratio:0.88
T/O Rate:0.91%
Dividend:0.74
Dividend Rate:2.16%
EPS(TTM):4.20
EPS(LYR):0.0434
ROE:14.12%
ROA:1.44%
PB:1.34
PE(LYR):787.49

Loading ...

Truist Securities Adjusts Vornado Realty Trust Price Target to $36 From $40, Maintains Hold Rating

MT Newswires Live
·
Dec 16

Vornado Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Dec 15

Vornado Realty Trust : Mizuho Cuts Target Price to $40 From $43

THOMSON REUTERS
·
Dec 12

Vornado Realty Trust Declares Dividend of $0.74 a Share, Payable Dec. 29 to Shareholders of Record Dec. 18

MT Newswires Live
·
Dec 09

Vornado Realty Trust announces $0.74 per share dividend

Reuters
·
Dec 09

Vornado (VNO) Valuation Check After 18% Year-to-Date Share Price Decline

Simply Wall St.
·
Dec 09

Assessing Vornado Realty Trust After Recent Share Price Weakness and DCF Upside Potential

Simply Wall St.
·
Dec 03

Henderson Land Development Files Directors List to HKEX

Reuters
·
Dec 01

PT International Development Corporation Files Directors List to HKEX

Reuters
·
Nov 30

JPMorgan Downgrades Vornado Realty Trust to Neutral From Underweight, $41 Price Target

MT Newswires Live
·
Nov 24

Vornado Raised to Neutral From Underweight by JP Morgan

Dow Jones
·
Nov 24

Vornado upgraded to Neutral from Underweight at JPMorgan

TIPRANKS
·
Nov 24

Cautious Hold on Vornado Realty Amid Strong Fundamentals and Elevated Valuation

TIPRANKS
·
Nov 24

U.S. RESEARCH ROUNDUP-Alignment Healthcare, BJ's Wholesale Club Holdings, Hyatt Hotels

Reuters
·
Nov 24

Vornado Realty Trust : JP Morgan Raises to Neutral From Underweight

THOMSON REUTERS
·
Nov 24

Vornado price target lowered to $38 from $40 at Scotiabank

TIPRANKS
·
Nov 13

LB Pharmaceuticals Expands One Penn Plaza Lease with Additional 4,634 Square Feet

Reuters
·
Nov 13

Vornado Realty Trust : Scotiabank Cuts Target Price to $38 From $40

THOMSON REUTERS
·
Nov 13

Ovid Therapeutics reports Q3 revenue of $132,000 and R&D expenses of $5.9 million

Reuters
·
Nov 12

Ovid Therapeutics Names Meg Alexander as CEO

Reuters
·
Nov 12